Hideyuki Ishida1, Keiichiro Ishibashi2, Takeo Iwama2. 1. Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. 05hishi@saitama-med.ac.jp. 2. Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Abstract
PURPOSE: The risk of malignant tumors developing in association with juvenile polyposis syndrome (JPS) was evaluated to explore the optimal treatment for this rare disease. METHODS: We reviewed the data on JPS cases reported in Japan between January, 1971 and March, 2016. RESULTS: A total of 171 cases were evaluable. Of these 171 patients, 83 (48.5%) were female and the median age at diagnosis was 28 years (range 1-80 years). The polyps were located in the stomach alone (n = 62; 36.3%), in the stomach and intestine (n = 47; 27.4%), or in the colorectum alone (n = 62; 36.3%). The sites of malignant tumors were the stomach (n = 31), colorectum (n = 29), small intestine (n = 2), breast (n = 1), and thyroid (n = 1). The lifetime risk (at 70 years) of any malignant tumor was 86.2%. The lifetime risk of gastric cancer was 73.0% and that of colorectal cancer was 51.1%. The risk of these cancers developing was dependent on the type of polyp distribution. CONCLUSIONS: Long-term surveillance of the stomach and colorectum based on the phenotype of JPS seems a reasonable approach to monitor these patients for the development of malignant tumors.
PURPOSE: The risk of malignant tumors developing in association with juvenile polyposis syndrome (JPS) was evaluated to explore the optimal treatment for this rare disease. METHODS: We reviewed the data on JPS cases reported in Japan between January, 1971 and March, 2016. RESULTS: A total of 171 cases were evaluable. Of these 171 patients, 83 (48.5%) were female and the median age at diagnosis was 28 years (range 1-80 years). The polyps were located in the stomach alone (n = 62; 36.3%), in the stomach and intestine (n = 47; 27.4%), or in the colorectum alone (n = 62; 36.3%). The sites of malignant tumors were the stomach (n = 31), colorectum (n = 29), small intestine (n = 2), breast (n = 1), and thyroid (n = 1). The lifetime risk (at 70 years) of any malignant tumor was 86.2%. The lifetime risk of gastric cancer was 73.0% and that of colorectal cancer was 51.1%. The risk of these cancers developing was dependent on the type of polyp distribution. CONCLUSIONS: Long-term surveillance of the stomach and colorectum based on the phenotype of JPS seems a reasonable approach to monitor these patients for the development of malignant tumors.
Authors: K Woodford-Richens; S Bevan; M Churchman; B Dowling; D Jones; C G Norbury; S V Hodgson; D Desai; K Neale; R K Phillips; J Young; B Leggett; M Dunlop; P Rozen; C Eng; D Markie; M A Rodriguez-Bigas; E Sheridan; T Iwama; D Eccles; G T Smith; J C Kim; K M Kim; J R Sampson; G Evans; S Tejpar; W F Bodmer; I P Tomlinson; R S Houlston Journal: Gut Date: 2000-05 Impact factor: 23.059
Authors: Suzanne P MacFarland; Jessica E Ebrahimzadeh; Kristin Zelley; Lubna Begum; Lee M Bass; Randall E Brand; Beth Dudley; Douglas S Fishman; Amanda Ganzak; Eve Karloski; Alicia Latham; Xavier Llor; Sharon Plon; Mary K Riordan; Sarah R Scollon; Zsofia K Stadler; Sapna Syngal; Chinedu Ukaegbu; Jennifer M Weiss; Matthew B Yurgelun; Garrett M Brodeur; Petar Mamula; Bryson W Katona Journal: Cancer Prev Res (Phila) Date: 2020-10-23
Authors: Xian Hua Gao; Juan Li; Zi Ye Zhao; Xiao Dong Xu; Yi Qi Du; Hong Li Yan; Lian Jie Liu; Chen Guang Bai; Wei Zhang Journal: BMC Gastroenterol Date: 2020-06-01 Impact factor: 3.067